New study shows that 30 days of microdosing is related to improvements in mood, mental health, and psychomotor abilities
These are the latest findings from the Microdose.me project, a crowd-sourced study on the effects of microdosing, powered by the Quantified Citizen app.
Published in Nature-Scientific Reports, the study followed 953 people who self-administered psilocybin microdoses and a second group of 180 people that were not microdosing.
This is a follow-up to last year’s huge microdosing study of over 19,000 participants (note: performed without placebo control), run by a group of respected scientists and academics, including the Mushroom Man himself, Paul Stamets. These types of self-reproted, observational studies might seem to be lacking when compared to more traditional clinical trials, but should not be discounted as they follow many of the same proceedures of more classic, in-person studies. There is a place for this kind of early-stage work, helping both researchers and companies with pre-clinical perspective and guidance.
See below for a look at the abstract and click here for the full report.
And stay tuned to Microdose for an interview with Quantified Citizen’s founder and CEO.
